New York-based mental health technology company Resilience Lab has acquired online psychiatric medication management platform Options MD, which will allow Resilience to offer integrated prescription management and psychotherapy services for moderate to severe mental illness. 

Resilience Lab is an online mental healthcare platform that connects patients with therapists who specialize in depression, anxiety, ADHD, PTSD, OCD and other concerns. 

The acquisition allows Resilience to integrate Options MD's medication management and psychotherapy offerings into its platform, giving patients with severe mental illness access to specialized clinicians for medication management. 

Resilience will also integrate Options' proprietary clinical intake and AI decision support platform into its software suite, providing its therapists with AI-enabled diagnosis and treatment recommendations to assist them in creating an effective care plan. 

Options MD's workforce will be retained by Resilience Lab, and Options MD will operate as a business unit of Resilience Lab under its own brand.

"This acquisition of Options MD gives Resilience Lab the ability to expand into more severe illnesses to more effectively address treatment needs with a systematic clinical approach with proven success," Christine Carville, chief clinical officer and cofounder of Resilience Lab, said in a statement. 

"The ability to increase the likelihood of receiving an accurate diagnosis and providing clients the most appropriate treatment that includes high-quality psychotherapy and state-of-the-art medication management is a win-win for those suffering from mental illness."

THE LARGER TREND

In 2022, Resilience Lab secured $15 million in Series A funding. That same year, Options MD scooped up $2.35 million in a pre-seed funding round led by Bread and Butter Ventures. 

Numerous acquisitions within the digital health sector have occurred this year, including the purchase by at-home diagnostics company LetsGetChecked of digital pharmacy and telehealth startup Truepill last week. 

In September, Kipu Health, a company that provides technology solutions for behavioral health, announced it had acquired Hatch Compliance, a cloud-based compliance-management and software provider. 

The same month, Finland-based health-tracking ring maker Oura announced it had entered into an agreement to acquire fellow Finnish company Veri, which offers personalized metabolic health programs. 

In August, Health Catalyst, a U.S.-based healthcare data and analytics provider for care organizations, acquired Lumeon, a Boston- and London-based care management automation startup.

Boston-based Uwill, a mental health platform for colleges and students, announced in July that it acquired Virtual Care Group, a fellow student-focused telehealth and wellness-support platform.